BioLife Solutions, Inc. (BLFS)
USD 24.98
(-7.03%)
USD 24.98
(-7.03%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 143.27 Million | 161.75 Million | 119.15 Million | 48.08 Million | 27.37 Million | 19.74 Million |
| Cost of Revenue | 96.51 Million | 107.93 Million | 81.4 Million | 20.64 Million | 8.85 Million | 6.21 Million |
| Gross Profit | 46.75 Million | 53.82 Million | 37.74 Million | 27.44 Million | 18.51 Million | 13.52 Million |
| Operating Expenses | 117.57 Million | 93.73 Million | 68.11 Million | 30.77 Million | 18.17 Million | 9.86 Million |
| Selling, General and Administrative Expenses | 80.3 Million | 69.24 Million | 48.09 Million | 21.02 Million | 14.05 Million | 8.56 Million |
| Research and Development Expenses | 18.79 Million | 14.79 Million | 11.81 Million | 6.72 Million | 4.12 Million | 1.29 Million |
| Other Expenses | 18.47 Million | 9.69 Million | 8.2 Million | 3.03 Million | 9.85 Million | 276 Thousand |
| Cost and Expenses | 214.09 Million | 201.67 Million | 149.52 Million | 51.41 Million | 27.03 Million | 16.08 Million |
| Operating Income | -70.82 Million | -39.91 Million | -30.36 Million | -3.33 Million | -781 Thousand | 3.66 Million |
| Interest Expense | 1.81 Million | 687 Thousand | 485 Thousand | 18 Thousand | 5000.00 | 5000.00 |
| Income Tax Expense | 169 Thousand | -5.02 Million | -20.3 Million | -3.26 Million | -1.54 Million | 396 Thousand |
| Earnings before Tax | -66.25 Million | -144.82 Million | -28.68 Million | -597 Thousand | 9.52 Million | 3.26 Million |
| Net Income | -66.42 Million | -139.8 Million | -8.38 Million | 2.66 Million | 11.06 Million | 3.26 Million |
| Earnings Per Share Basic | -1.52 | -3.29 | -0.22 | 0.10 | -0.09 | 0.20 |
| Earnings Per Share Diluted | -1.52 | -3.29 | -0.22 | 0.10 | -0.09 | 0.20 |
| Weighted Average Shares Outstanding | 43.71 Million | 42.48 Million | 38.5 Million | 27.3 Million | 19.46 Million | 16.25 Million |
| Weighted Average Shares Outstanding (Diluted) | 43.71 Million | 42.48 Million | 38.5 Million | 27.3 Million | 19.46 Million | 16.25 Million |
| Gross Margin | 0.33 | 0.33 | 0.32 | 0.57 | 0.68 | 0.69 |
| EBIT Margin | -0.32 | -0.18 | -0.20 | -0.06 | 0.04 | 0.19 |
| Profit Margin | -0.46 | -0.86 | -0.07 | 0.06 | 0.40 | 0.17 |
| EBITDA | -45.23 Million | -23.19 Million | -17.78 Million | 1.07 Million | -884 Thousand | -24.66 Million |
| Earnings Before Tax Margin | -0.49 | -0.25 | -0.25 | -0.07 | -0.03 | 0.19 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 28.32 Million | 31.72 Million | 143.27 Million | 32.73 Million | 33.32 Million | 39.5 Million |
| Cost of Revenue | 14.34 Million | 20.08 Million | 101.7 Million | 24.39 Million | 21.67 Million | 27.69 Million |
| Gross Profit | 13.98 Million | 11.64 Million | 41.57 Million | 8.33 Million | 11.64 Million | 11.81 Million |
| Operating Expenses | 16.77 Million | 21.53 Million | 99.1 Million | 21.9 Million | 26.52 Million | 28.01 Million |
| Selling, General and Administrative Expenses | 14.39 Million | 18 Million | - | 17.5 Million | 19.76 Million | 21.72 Million |
| Research and Development Expenses | 2.38 Million | 3.53 Million | - | 4.39 Million | 5.4 Million | 4.84 Million |
| Other Expenses | 84 Thousand | 245 Thousand | 1.26 Million | 237 Thousand | 242 Thousand | 390 Thousand |
| Cost and Expenses | 31.12 Million | 41.61 Million | 200.8 Million | 46.3 Million | 48.2 Million | 55.7 Million |
| Operating Income | -2.79 Million | -9.89 Million | -57.53 Million | -13.57 Million | -28.78 Million | -15.28 Million |
| Interest Expense | 361 Thousand | 207 Thousand | 1.81 Million | 507 Thousand | 476 Thousand | 419 Thousand |
| Income Tax Expense | 13.57 Million | 131 Thousand | 169 Thousand | -43 Thousand | 115 Thousand | 5000.00 |
| Earnings before Tax | -7.14 Million | -10.09 Million | -66.25 Million | -13.42 Million | -29.01 Million | -10.19 Million |
| Net Income | -11.82 Million | -10.22 Million | -66.42 Million | -13.38 Million | -29.13 Million | -10.19 Million |
| Earnings Per Share Basic | -0.26 | -0.22 | - | -0.30 | -0.67 | -0.23 |
| Earnings Per Share Diluted | -0.26 | -0.22 | - | -0.30 | -0.67 | -0.23 |
| Weighted Average Shares Outstanding | 46 Million | 45.43 Million | 43.71 Million | 44.82 Million | 43.57 Million | 43.44 Million |
| Weighted Average Shares Outstanding (Diluted) | 46 Million | 45.43 Million | 43.71 Million | 44.82 Million | 43.57 Million | 43.44 Million |
| Gross Margin | 0.49 | 0.37 | 0.29 | 0.25 | 0.35 | 0.30 |
| EBIT Margin | -0.01 | -0.24 | - | -0.34 | -0.34 | -0.36 |
| Profit Margin | -0.42 | -0.32 | -0.46 | -0.41 | -0.87 | -0.26 |
| EBITDA | -385 Thousand | -7.61 Million | - | -11.18 Million | -11.35 Million | -14.35 Million |
| Earnings Before Tax Margin | -0.10 | -0.31 | -0.40 | -0.41 | -0.86 | -0.39 |
CELC
IONM
VAIBHAVGBL
PNCINFRA
WINMED
1FC